Mostrando 721 - 740 Resultados de 16,624 Para Buscar '"hepatitis B"', tiempo de consulta: 1.14s Limitar resultados
  1. 721
    “…HepSEQ is a repository for an extensive library of public health and molecular data relating to hepatitis B virus (HBV) infection collected from international sources. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  2. 722
    “…This study was conducted to understand the symptomatology, attitudes, and behaviours of chronic hepatitis B (CHB) patients in the USA. CHB patients enrolled in this study were recruited through multiple methods, including newspaper advertisements. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  3. 723
    “…In the 18 years between 1970 and 1987, 504 patients were found to have hepatitis B surface antigen (HBsAg) in their blood. …”
    Enlace del recurso
    Enlace del recurso
    Texto
  4. 724
    por Tillmann, Hans Ludger
    Publicado 2008
    “…Several options for the treatment of hepatitis B have been licensed in the last years: interferon, pegylated interferon, lamivudine, adefovir, entecavir, and telbivudine. …”
    Enlace del recurso
    Enlace del recurso
    Texto
  5. 725
    “…We conducted a phylogenetic analysis of 19 hepatitis B virus strains from Laos that belonged to 2 subgenotypes of a new genotype I. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  6. 726
    “…Acute viral hepatitis B is cleared in more than 95% of patients, while the remainder ones may develop either chronic HBV infection or, rarely, fulminant hepatitis. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  7. 727
    por Datta, Sibnarayan
    Publicado 2008
    “…Hepatitis B virus (HBV) is one of the major global public health problems. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  8. 728
    “…Correction to Morelli G, Perrella A, Sbreglia C, Bellopede P, Riccio V, Perrella O: Antiviral therapy in acute viral hepatitis B: why and when. Infectious Agents and Cancer 2009, 4:2.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  9. 729
  10. 730
    “…BACKGROUND: Chronic hepatitis B and hepatitis B-associated liver cancer is a major health disparity among Vietnamese Americans, who have a chronic hepatitis B prevalence rate of 7–14% and an incidence rate for liver cancer six times that of non-Latino whites. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  11. 731
    “…BACKGROUND: Mononeuropathy multiplex is a rare complication during the course of chronic hepatitis B, despite various neuropathies following acute hepatitis B having been reported previously. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  12. 732
    “…Recommended treatment of chronic hepatitis B with interferon-α and/or nucleos(t)ide analogues does not lead to a satisfactory result. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  13. 733
  14. 734
  15. 735
    “…AIMS: To assess the value of transient elastography for predicting significant fibrosis or cirrhosis in chronic hepatitis B or C (CHB or CHC) patients. METHODS: 75 patients (CHB: 45, CHC: 32) were included. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  16. 736
    “…BACKGROUND: Areas that are endemic for malaria are also highly endemic for hepatitis B virus (HBV) infection. Nevertheless, it is unknown whether HBV infection modifies the clinical presentation of malaria. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  17. 737
    “…Recent data showed the efficacy of TDF in the treatment of chronically hepatitis B virus (HBV)-infected patients. TDF was superior to adefovir dipivoxil (ADV) in both nucleos(t)ide-naïve HBeAg-positive and HBeAg-negative HBV patients, and appeared to be one of the most potent antiviral agents so far. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  18. 738
    “…CONCLUSION: These results suggest the possibility of AAT as a potential biomarker for hepatitis B in diagnosis.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  19. 739
    “…BACKGROUND: Occult hepatitis B is defined as presence of HBV DNA in tissue or serum without hepatitis B surface antigen. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  20. 740
    “…Viral hepatitis is one of the major health problems worldwide, particularly in South East Asian countries including Pakistan where hepatitis C virus (HCV) and hepatitis B virus (HBV) infections are highly endemic. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
Herramientas de búsqueda: RSS